Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (401-410 of 664) with videos related to

Pageof 67
Sort By:
Onkologie|April 18, 2008
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC)Michael Görn, Christian R Habermann, Manuela Anige, et al.
Journal of Neuroimmunology|May 23, 2006
Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cellsDjordje Atanackovic, Benjamin Schnee, Gunter Schuch, et al.
Journal of Proteomics|March 1, 2015
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkersRamesh Ummanni, Divya Duscharla, Christine Barett, et al.
Oncotarget|April 24, 2018
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Kseniya M Tabakmakher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study groupKarin Oechsle, Michael Hartmann, Winfried Brenner, et al.
Haematologica|March 28, 2024
BCMA x CD3 T-cell engager in a patient with pentarefractory multiple myeloma and HIV: a clinical and immunological reportLeon Cords, Christoph Schaefers, Abdulaziz Kamili, et al.
Cancer Medicine|July 1, 2023
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatmentMatthäus Majewski, Pia Paffenholz, Christian Ruf, et al.
Thrombosis Research|September 20, 2016
Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48]Carlota Claussen, Alma-Verena Rausch, Susanne Lezius, et al.
Journal of Clinical Medicine|December 10, 2021
Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple MyelomaSusanne Ghandili, Martin Schönlein, Christian Wiessner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2018
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factorsChristoph Seidel, Gedske Daugaard, Alexey Tryakin, et al.
Pageof 67

Showing results (401-410 of 664) with videos related to

Sort By:
Pageof 67
Onkologie|April 18, 2008
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC)Michael Görn, Christian R Habermann, Manuela Anige, et al.
Journal of Neuroimmunology|May 23, 2006
Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cellsDjordje Atanackovic, Benjamin Schnee, Gunter Schuch, et al.
Journal of Proteomics|March 1, 2015
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkersRamesh Ummanni, Divya Duscharla, Christine Barett, et al.
Oncotarget|April 24, 2018
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Kseniya M Tabakmakher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study groupKarin Oechsle, Michael Hartmann, Winfried Brenner, et al.
Haematologica|March 28, 2024
BCMA x CD3 T-cell engager in a patient with pentarefractory multiple myeloma and HIV: a clinical and immunological reportLeon Cords, Christoph Schaefers, Abdulaziz Kamili, et al.
Cancer Medicine|July 1, 2023
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatmentMatthäus Majewski, Pia Paffenholz, Christian Ruf, et al.
Thrombosis Research|September 20, 2016
Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48]Carlota Claussen, Alma-Verena Rausch, Susanne Lezius, et al.
Journal of Clinical Medicine|December 10, 2021
Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple MyelomaSusanne Ghandili, Martin Schönlein, Christian Wiessner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2018
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factorsChristoph Seidel, Gedske Daugaard, Alexey Tryakin, et al.
Pageof 67